UB Paderborn / Katalog / Suche / in CDI

Synthesis and Pharmacological Characterization of 2‑(2,6-Dichlorophenyl)-1-((1S,3R)‑5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)‑yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor

Journal of medicinal chemistry, 2019-10, Vol.62 (19), p.8711-8732

2019

Volltextzugriff (PDF)

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain

Naunyn-Schmiedeberg's archives of pharmacology, 2005-03, Vol.371 (3), p.178-184

2005

Volltextzugriff (PDF)

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

The Journal of pharmacology and experimental therapeutics, 2017-01, Vol.360 (1), p.117

2017

Volltextzugriff (PDF)

Synthesis, Ex Vivo Evaluation, and Radiolabeling of Potent 1,5-Diphenylpyrrolidin-2-one Cannabinoid Subtype-1 Receptor Ligands as Candidates for In Vivo Imaging

Journal of medicinal chemistry, 2008-09, Vol.51 (18), p.5833-5842

2008

Volltextzugriff (PDF)

The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain

Neuropsychopharmacology (New York, N.Y.), 2008-01, Vol.33 (2), p.259-269

2008

Volltextzugriff (PDF)

Comparison of a Pharmacist-Performed and Physician or Advanced Practice Provider–Performed Medication History in Pediatric Patients

The Journal of pharmacy technology, 2015-10, Vol.31 (5), p.219-222

2015

Volltextzugriff (PDF)

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties

Naunyn-Schmiedeberg's archives of pharmacology, 2005-03, Vol.371 (3), p.169-177

2005

Volltextzugriff (PDF)

Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP

European journal of pharmacology, 2010-12, Vol.649 (1-3), p.44-50

2010

Volltextzugriff (PDF)

The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor

Journal of medicinal chemistry, 1988-07, Vol.31 (7), p.1412-1417

1988

Volltextzugriff (PDF)

Indoloxypropanolamine analogues as 5-HT1A receptor antagonists

Bioorganic & medicinal chemistry letters, 2007-10, Vol.17 (20), p.5600-5604

2007

Volltextzugriff (PDF)

Radiolabeling of a high potency cannabinoid subtype-1 receptor ligand, N-(4-fluoro-benzyl)-4-(3-(piperidin-1-yl)-indole-1-sulfonyl)benzamide (PipISB), with carbon-11 or fluorine-18

Journal of labelled compounds & radiopharmaceuticals, 2008-03, Vol.51 (3), p.146-152

2008

Volltextzugriff (PDF)

LY248686, a new inhibitor of serotonin and norepinephrine uptake

Neuropsychopharmacology (New York, N.Y.), 1993, Vol.8 (1), p.23-33

1993

Volltextzugriff (PDF)

Indoloxypropanolamine analogues as 5-HT(1A) receptor antagonists

Bioorganic & medicinal chemistry letters, 2007-10, Vol.17 (20), p.5600-5604

2007

Volltextzugriff (PDF)

Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-spiro[cycloalkane-1,3'-[3H]indol]-2'(1'H)-ones

Journal of medicinal chemistry, 1987-05, Vol.30 (5), p.824-829

1987

Volltextzugriff (PDF)

Dihydropyridazinone cardiotonics. The discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one

Journal of medicinal chemistry, 1986-10, Vol.29 (10), p.1832-1840

1986

Volltextzugriff (PDF)

Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain

Neuropsychopharmacology (New York, N.Y.), 1993-06, Vol.8 (4), p.337-344

1993

Volltextzugriff (PDF)

Pharmacological characterization of the cannabinoid CB 1 receptor PET ligand ortholog, [ 3H]MePPEP

European journal of pharmacology, 2010, Vol.649 (1), p.44-50

2010

Volltextzugriff (PDF)

Synthesis of Homochiral 2-(2-Arylethyl)piperazines

Synthesis (Stuttgart), 2007-08, Vol.2007 (15), p.2307-2312

2007

Volltextzugriff (PDF)

Synthesis, Ex Vivo Evaluation and Radiolabeling of Potent 1,5-Diphenyl-pyrrolidin-2-one Cannabinoid Subtype-1 (CB1) Receptor Ligands as Candidates for In Vivo Imaging

Journal of medicinal chemistry, 2008-09, Vol.51 (18), p.5833-5842

2008

Volltextzugriff (PDF)

Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine

Journal of medicinal chemistry, 1985-06, Vol.28 (6), p.717-727

1985

Volltextzugriff (PDF)

Localization of ATP sensitive potassium channels in the rat brain using a novel radioligand, [ 125I]iodoglibenclamide

European journal of pharmacology, 1990-09, Vol.186 (2), p.373-375

1990

Volltextzugriff (PDF)

Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol

Journal of medicinal chemistry, 1986-09, Vol.29 (9), p.1577-1586

1986

Volltextzugriff (PDF)

Expedient synthesis and biochemical properties of an [125I]-labeled analogue of glyburide, a radioligand for ATP-inhibited potassium channels

Journal of medicinal chemistry, 1990-12, Vol.33 (12), p.3124-3126

1990

Volltextzugriff (PDF)

Synthesis of a tritium-labeled indolidan analog and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites

Journal of medicinal chemistry, 1989-07, Vol.32 (7), p.1476-1480

1989

Volltextzugriff (PDF)

Molecular structure of the dihydropyridazinone cardiotonic 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one, a potent inhibitor of cyclic AMP phosphodiesterase

Journal of medicinal chemistry, 1987-04, Vol.30 (4), p.623-627

1987

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain

An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis

Synthesis, Ex Vivo Evaluation, and Radiolabeling of Potent 1,5-Diphenylpyrrolidin-2-one Cannabinoid Subtype-1 Receptor Ligands as Candidates for In Vivo Imaging

The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain

Comparison of a Pharmacist-Performed and Physician or Advanced Practice Provider–Performed Medication History in Pediatric Patients

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties

Pharmacological characterization of the cannabinoid CB1 receptor PET ligand ortholog, [3H]MePPEP

The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor

Indoloxypropanolamine analogues as 5-HT1A receptor antagonists

Radiolabeling of a high potency cannabinoid subtype-1 receptor ligand, N-(4-fluoro-benzyl)-4-(3-(piperidin-1-yl)-indole-1-sulfonyl)benzamide (PipISB), with carbon-11 or fluorine-18

LY248686, a new inhibitor of serotonin and norepinephrine uptake

Indoloxypropanolamine analogues as 5-HT(1A) receptor antagonists

Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-spiro[cycloalkane-1,3'-[3H]indol]-2'(1'H)-ones

Dihydropyridazinone cardiotonics. The discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one

Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain

Pharmacological characterization of the cannabinoid CB 1 receptor PET ligand ortholog, [ 3H]MePPEP

Synthesis of Homochiral 2-(2-Arylethyl)piperazines

Synthesis, Ex Vivo Evaluation and Radiolabeling of Potent 1,5-Diphenyl-pyrrolidin-2-one Cannabinoid Subtype-1 (CB1) Receptor Ligands as Candidates for In Vivo Imaging

Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine

Localization of ATP sensitive potassium channels in the rat brain using a novel radioligand, [ 125I]iodoglibenclamide

Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol

Expedient synthesis and biochemical properties of an [125I]-labeled analogue of glyburide, a radioligand for ATP-inhibited potassium channels

Synthesis of a tritium-labeled indolidan analog and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites

Molecular structure of the dihydropyridazinone cardiotonic 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one, a potent inhibitor of cyclic AMP phosphodiesterase

Suchergebnisse filtern